Over the past 25 years, the US prevalence of adolescent and adult depression indicators has increased.
1,2 However, national epidemiologic information on major depressive disorder (MDD) is limited to pre–
DSM-5 studies conducted more than 15 years ago. The
DSM-IV diagnosis of MDD was associated with impairment,
3,4 psychiatric and substance use disorders (SUDs),
5-9 poor health,
10,11 mortality,
12 disease and economic burden,
12 and disability-years.
13-16 Updated knowledge is needed on the prevalence of MDD and its association with sociodemographic and clinical characteristics, including other psychiatric disorders, suicidality, impairment, and treatment use.